-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203.O1.6 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Delineating Immunity from Mice to Humans

Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, autoimmune disorders, Lymphoid Leukemias, Fundamental Science, clinical trials, Lymphomas, Translational Research, epidemiology, autoimmune hemolytic anemia, Genetic Disorders, LGL, B Cell lymphoma, Clinical Research, health outcomes research, drug development, Diseases, Immune Disorders, immunodeficiency, Therapies, immunology, neutropenia, Lymphoid Malignancies, Biological Processes, molecular biology, pathogenesis
Monday, December 12, 2022: 10:30 AM-12:00 PM
278-282 (Ernest N. Morial Convention Center)
Moderators:
Jennifer N. Saultz, DO, The Ohio State University and Roshini S. Abraham, PhD, Nationwide Childrens Hospital
Disclosures:
Abraham: Beckman Coulter: Honoraria; Enzyvant: Consultancy, Honoraria.
This symposium will highlight cutting-edge pre-clinical and clinical studies aimed at increasing our understanding of lymphocytes and their contribution to the pathophysiology of acquired or congenital immunodeficiency disorders.
10:30 AM

Grace McAuley, BS1*, Gloria Yiu2*, Gregory A. Newby, PhD3*, Beatriz Campo Fernandez1*, Xiaomeng Wu1*, Patrick Chang4*, Kelcee Everette5*, Zulema Romero Garcia, PhD6*, David R. Liu, PhD7*, Gay M. Crooks, MD8,9 and Donald B. Kohn, MD10

1Department of Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, CA
2Department of Rheumatology, UCLA, Los Angeles
3Broad Institute of Harvard and MIT, Harvard University, Cambridge, MA
4Department of Pathology & Laboratory Medicine, UCLA, Los Angeles
5Broad Institute of MIT and Harvard, Cambridge, MA
6MIMG, UCLA, Los Angeles, CA
7Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA
8Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
9Division of Pediatric Hematology-Oncology, UCLA, Los Angeles
10Broad Institute of Harvard and MIT, University of California - Los Angeles, Los Angeles, CA

10:45 AM

V. Koneti Rao, MD1, Sharon Webster, BSN1*, Anna Sediva, MD, PhD2*, Alessandro Plebani, MD, PhD3*, Catharina Schuetz, MD, MSc4*, Anna Shcherbina, MD5*, Virgil A.S.H. Dalm, MD, PhD6*, Antonino Trizzino, MD7*, Yulia Zharankova, MD8*, Elaine Kulm, MS, CRNP-AC9*, Alanvin Orpia, BSN, RN1*, Lavenda Chirombo Kluczynski, MS1*, Julia Körholz, MD10*, Vassilios Lougaris, MD, PhD3*, Yulia Rodina, MD, PhD5*, Klaus Kucher, MD11*, Kath Radford12*, Jason Bradt, MD, MBA13* and Gulbu Uzel, MD1*

1LCIM DIR, NIAID National Institutes of Health, Bethesda, MD
2Department of Immunology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic
3Pediatrics Clinic, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy
4Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
5Department of Immunology, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
6Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus MC University Medical Center, Rotterdam, Netherlands
7Department of Pediatric Hematology and Oncology, ARNAS Civico Di Cristina Benfratelli Hospital, Palermo, Italy
8Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus
9Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Bethesda, MD
10Department of Pediatric Immunology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
11Novartis Institutes for Biomedical Research, Basel, Switzerland
12Novartis Pharmaceuticals UK Limited, London, United Kingdom
13Pharming Healthcare Inc, Warren, NJ

11:00 AM

Deepak Kumar, PhD1*, Chengyu Prince, BS1*, Tyler Hulett, PhD2*, Pedro Ramos, BS2*, Oscar Candelario, BS2*, Laura Youngblood, NP3*, Michael Briones, DO1*, Carolyn Bennett, MD1 and Shanmuganathan Chandrakasan, MD4

1Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
2CDI Laboratories Inc., Mayaguez, PR
3Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta, Atlanta, GA
4Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Decatur, GA

11:15 AM

Kameron Kooshesh, MD1,2,3*, Karin Gustafsson, PhD1,2,3*, Brody Foy, DPhil4*, David Sykes, MD, PhD2 and David T. Scadden, MD1,2,3

1Harvard Stem Cell Institute, Cambridge, MA
2Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
3Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
4Center for Systems Biology, Harvard Medical School & Massachusetts General Hospital, Boston, MA

11:30 AM

Saber Tadros, MD1*, Shamik Majumdar, PhD2*, Ottavia Delmonte, MD3*, Jenna Bergerson, MD4*, Irene Cortese, MD5*, David H. McDermott, MD2*, Jaspal Khillan, PhD6*, Kyoungin Cho, PhD6*, Luigi D. Notarangelo, MD3*, Philip M. Murphy, MD2* and Katherine R. Calvo, MD, PhD7

1Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD
2Laboratory of Molecular Immunology, Division of Intramural Research, NIAID, NIH, Bethesda, MD
3Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD
4Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD
5Experimental Immunotherapeutics Unit, NINDS, NIH, Bethesda, MD
6Comparative Medicine Branch, Division of Intramural Research, NIAID, NIH, Bethesda, MD
7Hematology Section, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD

11:45 AM

Alex Chen1*, Giacomo Tampella2*, Alfredo Quijano-Rubio1*, Matt Walker1*, Irene Barber1*, Justin Hare1*, Justin Huard1*, Danielle Van Citters1*, Aaron Moss1*, Hector Rincon1* and Bill Arthur1*

1Neoleukin Therapeutics, Inc., Seattle, WA
2Research, Neoleukin Therapeutics, Inc., Seattle, WA

*signifies non-member of ASH